A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Avidity Biosciences
Start Date
July 15, 2025
End Date
December 31, 2028
Administered By
Neurology, Neuromuscular Disease
Awarded By
Avidity Biosciences
Start Date
July 15, 2025
End Date
December 31, 2028